SUDAFED SINUS ADVANCE 200 MG
IBUPROFEN : 200 MG PSEUDOEPHEDRINE HYDROCHLORIDE : 30 MG · DIN 02242217 · MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
Health Canada status: MARKETED
What is SUDAFED SINUS ADVANCE?
SUDAFED SINUS ADVANCE 200 MG contains IBUPROFEN : 200 MG PSEUDOEPHEDRINE HYDROCHLORIDE : 30 MG. It is listed in the Health Canada Drug Product Database under DIN 02242217, held by MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC, supplied as TABLET for ORAL administration. Health Canada currently lists it as marketed, status dated 15-May-2026. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is SUDAFED SINUS ADVANCE used for?
SUDAFED® SINUS ADVANCE (Ibuprofen / Pseudoephedrine Hydrochloride) is indicated for temporary relief of symptoms associated with the common cold, sinusitis or flu including nasal congestion, headache, fever, body aches and pains. It is indicated in pediatric patients ≥ 12 years of age for the treatment of symptoms of colds including nasal congestion, sinus pain, headache, fever, body aches and pains.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02242217 |
|---|---|
| Brand name | SUDAFED SINUS ADVANCE |
| Generic / active ingredient | IBUPROFEN : 200 MG PSEUDOEPHEDRINE HYDROCHLORIDE : 30 MG |
| Manufacturer | MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC |
| Strength | 200 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | M01AE51 IBUPROFEN, COMBINATIONS |
| AHFS class | 28:08.04.92 ; 12:12.12 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 15-May-2026 |
| Original market date | 2000-08-01 00:00:00 |
How is this product identified?
Purchase orders, customs paperwork and tender documents each ask for a different identifier, and a DIN written without its leading zeros is the single most common reason an order line fails to match. Every form Nexara accepts for this product is listed here.
| DIN (8-digit, as used in Nexara ordering) | 02242217 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2242217 |
| Brand name | SUDAFED SINUS ADVANCE |
| Active ingredient / INN | IBUPROFEN : 200 MG PSEUDOEPHEDRINE HYDROCHLORIDE : 30 MG |
| ATC code | M01AE51 |
| ATC anatomical main group | M — Musculo-skeletal system |
| ATC therapeutic subgroup | M01 |
| AHFS class | 28:08.04.92 ; 12:12.12 |
| Health Canada schedule | NON-PRESCRIPTION DRUGS |
| Biosimilar biologic | No |
| Market authorization holder | MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC |
How is it stored and handled?
null
How is it supplied?
20 and 40 caplets
Which pack is which?
| Strength on the label | 200 MG |
|---|---|
| Dosage form | TABLET |
| Route | ORAL |
| Packaging as described in the monograph | 20 and 40 caplets |
| Storage | null |
One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced. Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
What can be used instead?
Other Canadian products sharing ATC code M01AE51 IBUPROFEN, COMBINATIONS. 13 of 40 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| ADVIL COLD & SINUS CONVENIENCE PACK | 2 MG | KIT ; TABLET | GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC | MARKETED | DIN 02399733 |
| ADVIL COLD & SINUS LIQUI-GELS | 200 MG | CAPSULE | GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC | MARKETED | DIN 02250705 |
| ADVIL COLD & SINUS PLUS | 30 MG | TABLET | HALEON CANADA ULC | MARKETED | DIN 02248645 |
| ADVIL COLD AND SINUS | 200 MG | TABLET | GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC | MARKETED | DIN 02036312 |
| ADVIL COLD AND SINUS DAYTIME | 200 MG | TABLET | GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC | MARKETED | DIN 02267616 |
| ADVIL COLD AND SINUS NIGHTTIME | 30 MG | TABLET | HALEON CANADA ULC | MARKETED | DIN 02267632 |
| ADVIL COLD, SINUS & FLU EXTRA STRENGTH | 4 MG | TABLET | HALEON CANADA ULC | MARKETED | DIN 02471604 |
| ADVIL FLU | 200 MG | CAPSULE | HALEON CANADA ULC | MARKETED | DIN 02401193 |
| ADVIL NIGHTTIME | 200 MG | CAPSULE | GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC | MARKETED | DIN 02355841 |
| COLD + SINUS | 200 MG | TABLET | VITA HEALTH PRODUCTS INC | MARKETED | DIN 02352281 |
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.